GlassScriptPhysician profile
Judith Elinor Lea
NPI 1366577066
$8,091.09
in general payments reported to CMS, 2019-2025
14 companies · $611 in 2025
The $611 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,757 · 2022: $3,706 · 2023: $340 · 2024: $677 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,628.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $6,463.04 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $245.65 | 2023-2024 | |
| Galderma Laboratories, L.P. | $139.54 | 2025 | Nemluvio |
| Edwards Lifesciences Corporation | $136.55 | 2025 | Sapien 3 Ultra Resilia |
| Neurelis, INC. | $134.34 | 2025 | Valtoco |
| Genzyme Corporation | $124.83 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $121.82 | 2023 | Andexxa |
| Averitas Pharma INC. | $121.82 | 2024 | Qutenza |
| Argenx US, INC. | $115.14 | 2025 | Vyvgart |
| Sage Therapeutics, LLC | $106.67 | 2024 | |
| Hologic Sales and Service, LLC | $104.91 | 2024 | Aptima |
| Acadia Pharmaceuticals INC | $97.18 | 2024 | Nuplazid |
| Biogen, INC. | $94.38 | 2023 | |
| Amgen INC. | $85.22 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Lea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.